Ontology highlight
ABSTRACT:
INSTRUMENT(S): TripleTOF 6600
ORGANISM(S): Homo Sapiens (ncbitaxon:9606)
SUBMITTER: Anxo Fernandez Ferreiro
PROVIDER: MSV000095892 | MassIVE |
REPOSITORIES: MassIVE
Investigative ophthalmology & visual science 20241101 13
<h4>Purpose</h4>Adalimumab (ADA) is a systemic biological treatment option approved for the treatment of noninfectious uveitis (NIU); however, up to 40% of patients do not respond to the drug, either in a primary or secondary manner. Here, we evaluated the proteomic profile of patients with NIU who fail to ADA to identify proteins implicated in intraocular inflammation, as well as potential biomarkers for treatment response and novel therapeutic targets.<h4>Methods</h4>Cross-sectional observatio ...[more]